From structural biology to precision medicine-decoding the key receptor in thyroid disorders
Related Experiment Video
Updated: Aug 14, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1Department of Child Health Care and Rehabilitation, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Abstract:
The thyroid‑stimulating hormone receptor (TSHR), a major autoantigen, has become a druggable precision‑medicine target in thyroid disorders. Recent cryo‑EM advances have clarified the dual‑mode activation and allosteric landscape of this receptor, boosting the development of novel therapeutics that include blocking antibodies, pathway‑specific small molecules and TSHR-IGF‑1R crosstalk inhibitors. Functional antibody subtyping and receptor‑targeted imaging also improve diagnostic accuracy. This review summarizes TSHR translational progress, illustrating how mechanistic findings support novel diagnostics, targeted agents and curative immunotherapies.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Graves Disease II: Pathophysiology
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Signal Transduction: Overview
Typically, signal transduction involves three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
